Landscapes / Companies
Halia Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials
Trials
2 active
7 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | Feb 2028Phase 2 trial completes | |||
| Next date | Feb 2028 · Phase 2 trial completes | ||||
| Also tested for | Alzheimers Disease | ||||
| Open drug page | |||||
— |
Phase 2 | Oct 2028Phase 2 trial completes | |||
| Next date | Oct 2028 · Phase 2 trial completes | ||||
| Also tested for | Myelodysplastic Syndromes, Anemia | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021